Variant report
Variant | nsv520316 |
---|---|
Chromosome Location | chr12:75740883-75753243 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566575492 | chr12:75743662-75743663 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182157077 | chr12:75743669-75743670 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141047627 | chr12:75743703-75743704 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551213062 | chr12:75743737-75743738 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567665657 | chr12:75743741-75743742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77455156 | chr12:75743759-75743760 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs372685196 | chr12:75743774-75743775 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530161635 | chr12:75743775-75743776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547002195 | chr12:75743794-75743795 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535900238 | chr12:75743808-75743809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567001458 | chr12:75743811-75743812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539097698 | chr12:75743816-75743817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35086570 | chr12:75743835-75743836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150242237 | chr12:75743858-75743859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544385803 | chr12:75743884-75743885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186807984 | chr12:75743892-75743893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs113234759 | chr12:75743912-75743913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116452812 | chr12:75743928-75743929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143294086 | chr12:75743984-75743985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542248490 | chr12:75743988-75743989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs147466090 | chr12:75744031-75744032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375409938 | chr12:75744051-75744052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545054288 | chr12:75744085-75744086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs368052342 | chr12:75744104-75744105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565343492 | chr12:75744115-75744116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs575744111 | chr12:75744131-75744132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371520913 | chr12:75744144-75744145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561606068 | chr12:75744226-75744227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371447344 | chr12:75744251-75744252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530397951 | chr12:75744266-75744267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547040760 | chr12:75744330-75744331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138309149 | chr12:75744471-75744472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192486908 | chr12:75744473-75744474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs143804351 | chr12:75744476-75744477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552594261 | chr12:75744508-75744509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569250642 | chr12:75744509-75744510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537293389 | chr12:75744528-75744529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147273824 | chr12:75744529-75744530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567250676 | chr12:75744534-75744535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536113845 | chr12:75744597-75744598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542686313 | chr12:75744607-75744608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552564721 | chr12:75744630-75744631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs117941150 | chr12:75744633-75744634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs183082657 | chr12:75744692-75744693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs10879902 | chr12:75744711-75744712 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs12830499 | chr12:75744724-75744725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs561503209 | chr12:75744749-75744750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544819670 | chr12:75744760-75744761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148733240 | chr12:75744781-75744782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575229452 | chr12:75744824-75744825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:75743600-75743800 | Weak transcription | Psoas Muscle | Psoas |
2 | chr12:75743600-75744600 | Enhancers | Fetal Thymus | thymus |
3 | chr12:75743800-75744200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr12:75743800-75744400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr12:75743800-75744400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr12:75743800-75744600 | Enhancers | Psoas Muscle | Psoas |
7 | chr12:75744000-75744400 | Enhancers | Thymus | Thymus |
8 | chr12:75744000-75744600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
9 | chr12:75744000-75745400 | Enhancers | Dnd41 | blood |
10 | chr12:75749400-75749800 | ZNF genes & repeats | Breast Myoepithelial Primary Cells | Breast |
11 | chr12:75749600-75782800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr12:75749800-75771800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |